EVIO, Inc. (EVIO) CEO Discusses Growing Need for R
Post# of 2022
(Total Views: 240)
Posted On: 05/18/2018 7:17:40 PM
EVIO, Inc. (EVIO) CEO Discusses Growing Need for Reliable Cannabis Testing, Industry Investment Opportunities at The MoneyShow Las Vegas
- CEO and co-founder William Waldrop attended several events, detailed his company’s operations and growth plans in the context of a rapidly expanding cannabis market with its associated auxiliary services
- Special Cannabis Investing Event was included in The MoneyShow Las Vegas schedule, with prominent industry speakers in attendance
- Topics of discussion revolved around medical and recreational marijuana, ancillary services, investment opportunities, leading companies and more
The rapid expansion of the cannabis industry over the last couple of years took center stage at The MoneyShow Las Vegas on May 14-16, with multiple workshops, meetings and panels organized as part of a special Cannabis Investing Event. With the cannabis industry rapidly growing, it is garnering the attention and interest of many investors. Prominent industry speakers from multiple cannabis-related sectors attended the event, taking the opportunity to tackle a wide range of relevant topics and important trends that cannabis investors need to know. The list of speakers included William Waldrop, CEO of EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing and research services for the regulated industry (http://nnw.fm/s2Mjw).
Waldrop had multiple speaking engagements during the Las Vegas event, starting with a special session tackling cannabis testing, organized on Tuesday, May 15. The speaking session, called “Intro to EVIO and Cannabis Testing,” (http://nnw.fm/sR1uL) focused on the growing need and demand for reliable cannabis testing in the context of a rapidly expanding market in which quality control assurances are paramount, as the use of cannabis and cannabinoids, especially for medical purposes, continues to grow. Talks also touched on the latest regulations and standards in the industry, but mostly focused on EVIO and its EVIO Labs division, which provides coast-to-coast accredited cannabis testing services via 11 testing facilities.
An established national leader in cannabis testing and verification, along with detection of possible harmful components that can compromise product quality and consumer health, EVIO also provides consulting services to cannabis producers and growers in an effort to help them meet quality goals, optimize their growing process and achieve regulatory compliance.
The EVIO CEO was also one of the guest speakers at the Cannabis Investing Event’s panel on “Recreational Marijuana: A Major Opportunity for Investors,” on May 15 (http://nnw.fm/GQf2H). Speakers at the panel discussed the significant opportunities associated with the recreational marijuana market, both for investors and for companies already active in the niche, from Canada (set to legalize recreational use this summer) to California (which voted to legalize the drug in a statewide poll in November 2016). Canada and California are currently the largest cannabis markets in the world, a fact that came into focus at The MoneyShow Las Vegas, with special sessions dedicated to the introduction of cannabis experts capitalizing on these two markets.
Another major speaking engagement for EVIO was “Taking the Guesswork out of Cannabis,” organized on Wednesday, May 16 (http://nnw.fm/6HEdu). The main topic of discussion during this workshop was how companies can “profit from the plant without touching the plant,” and it provided an extensive overview of the cannabis market’s ancillary services sector and the alternative investment opportunities that it presents. Discussion topics included the need for testing labs and how these facilities serve as gatekeepers, monitoring the safety and quality of cannabis before it is marketed to consumers. Auxiliary services include, among others, laboratory testing, consulting, compliance, extraction equipment, packaging, software development, staffing, security, media and publishing.
Founded in 1981, MoneyShow’s annual live and online events tackling major investment and trading topics have attracted tens of thousands of investors, advisors, traders and market experts. MoneyShow began covering the legal cannabis industry in February 2015, with this year’s event focusing on several key themes for 2018, such as biotech and medical marijuana, the United States marijuana revolution and the companies at its forefront, investing in cannabis and much more.
For EVIO, the MoneyShow participation follows on the heels of its expansion into the international market with its recent 100 percent acquisition of Leaf Detective, LLC in California and it 50 percent acquisition of Keystone Labs Inc. in Canada. These strategic acquisitions position EVIO for sustained growth in the world’s largest cannabis markets, and the company is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.
For more information, visit the company’s website at www.EVIOLabs.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- CEO and co-founder William Waldrop attended several events, detailed his company’s operations and growth plans in the context of a rapidly expanding cannabis market with its associated auxiliary services
- Special Cannabis Investing Event was included in The MoneyShow Las Vegas schedule, with prominent industry speakers in attendance
- Topics of discussion revolved around medical and recreational marijuana, ancillary services, investment opportunities, leading companies and more
The rapid expansion of the cannabis industry over the last couple of years took center stage at The MoneyShow Las Vegas on May 14-16, with multiple workshops, meetings and panels organized as part of a special Cannabis Investing Event. With the cannabis industry rapidly growing, it is garnering the attention and interest of many investors. Prominent industry speakers from multiple cannabis-related sectors attended the event, taking the opportunity to tackle a wide range of relevant topics and important trends that cannabis investors need to know. The list of speakers included William Waldrop, CEO of EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing and research services for the regulated industry (http://nnw.fm/s2Mjw).
Waldrop had multiple speaking engagements during the Las Vegas event, starting with a special session tackling cannabis testing, organized on Tuesday, May 15. The speaking session, called “Intro to EVIO and Cannabis Testing,” (http://nnw.fm/sR1uL) focused on the growing need and demand for reliable cannabis testing in the context of a rapidly expanding market in which quality control assurances are paramount, as the use of cannabis and cannabinoids, especially for medical purposes, continues to grow. Talks also touched on the latest regulations and standards in the industry, but mostly focused on EVIO and its EVIO Labs division, which provides coast-to-coast accredited cannabis testing services via 11 testing facilities.
An established national leader in cannabis testing and verification, along with detection of possible harmful components that can compromise product quality and consumer health, EVIO also provides consulting services to cannabis producers and growers in an effort to help them meet quality goals, optimize their growing process and achieve regulatory compliance.
The EVIO CEO was also one of the guest speakers at the Cannabis Investing Event’s panel on “Recreational Marijuana: A Major Opportunity for Investors,” on May 15 (http://nnw.fm/GQf2H). Speakers at the panel discussed the significant opportunities associated with the recreational marijuana market, both for investors and for companies already active in the niche, from Canada (set to legalize recreational use this summer) to California (which voted to legalize the drug in a statewide poll in November 2016). Canada and California are currently the largest cannabis markets in the world, a fact that came into focus at The MoneyShow Las Vegas, with special sessions dedicated to the introduction of cannabis experts capitalizing on these two markets.
Another major speaking engagement for EVIO was “Taking the Guesswork out of Cannabis,” organized on Wednesday, May 16 (http://nnw.fm/6HEdu). The main topic of discussion during this workshop was how companies can “profit from the plant without touching the plant,” and it provided an extensive overview of the cannabis market’s ancillary services sector and the alternative investment opportunities that it presents. Discussion topics included the need for testing labs and how these facilities serve as gatekeepers, monitoring the safety and quality of cannabis before it is marketed to consumers. Auxiliary services include, among others, laboratory testing, consulting, compliance, extraction equipment, packaging, software development, staffing, security, media and publishing.
Founded in 1981, MoneyShow’s annual live and online events tackling major investment and trading topics have attracted tens of thousands of investors, advisors, traders and market experts. MoneyShow began covering the legal cannabis industry in February 2015, with this year’s event focusing on several key themes for 2018, such as biotech and medical marijuana, the United States marijuana revolution and the companies at its forefront, investing in cannabis and much more.
For EVIO, the MoneyShow participation follows on the heels of its expansion into the international market with its recent 100 percent acquisition of Leaf Detective, LLC in California and it 50 percent acquisition of Keystone Labs Inc. in Canada. These strategic acquisitions position EVIO for sustained growth in the world’s largest cannabis markets, and the company is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.
For more information, visit the company’s website at www.EVIOLabs.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)